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Activation of phospholipase C-dependent inositol
polyphosphate signaling pathways generates distinct
messengers derived from inositol 1,4,5-trisphosphate
that control gene expression and mRNA export. Here we
report the regulation of telomere length by production
of a diphosphorylinositol tetrakisphosphate, PP-IP4,
synthesized by the KCS1 gene product. Loss of PP-IP4
production results in lengthening of telomeres, whereas
overproduction leads to their shortening. This effect
requires the presence of Tel1, the yeast homologue of
ATM, the protein mutated in the human disease ataxia
telangiectasia. Our data provide in vivo evidence of a
regulatory link between inositol polyphosphate signal-
ing and the checkpoint kinase family and describe a
third nuclear process modulated by phospholipase C
activation.
Appropriate cellular responses to environmental changes in-
volve intracellular second messenger systems that transduce
the signals from cytoplasm to nucleus, thereby initiating adap-
tive genetic programs. One well described intracellular mes-
senger system works through receptor-coupled activation of
phospholipase C (PLC),1 which hydrolyzes phosphatidylinosi-
tol 4,5-bisphosphate to yield inositol 1,4,5-trisphosphate (IP3)
(reviewed in Refs. 1 and 2). In metazoans, cellular production of
IP3 functions as a signal for calcium release from intracellular
stores through allosteric activation of an IP3 receptor channel.
Recent studies indicate that IP3 also plays an important role as
precursor to multiple inositol polyphosphates (IPs), each with
potentially unique signaling capability (reviewed in Ref. 3).
This signaling potential is not restricted to the cytoplasm,
because IPs are known to function in nuclear processes in
budding yeast (reviewed in Ref. 4). Activation of yeast phos-
pholipase C (Plc1) produces IP3, which is rapidly phosphoryl-
ated by the dual specificity 6-/3-kinase Ipk2 (initially cloned as
ArgRIII/Arg82 (5)) to yield IP4 and IP5 (6–8). This phosphoryl-
ation step is coupled to transcriptional regulation, possibly
through chromatin remodeling (7, 9–11). IP5 is then phospho-
rylated by the 2-kinase Ipk1, generating IP6, which is required
for efficient mRNA export from the nucleus (12–14). Both IP5
and IP6 can be converted to the diphosphoryl inositols PP-IP4
and PP-IP5 through the action of Kcs1, a kinase required for
normal vacuolar morphology (15–18). PP-IP5 has recently been
suggested to play a role in chemotaxis in Dictyostelium (19). A
nuclear role for Kcs1 is implied by its initial cloning as a
regulator of mitotic DNA recombination, and inositol kinase
activity is required for this regulation, but further understand-
ing of its nuclear activity is lacking (20, 21).
Recent work has provided further linking of IP production
and nuclear function through an important family of protein
serine/threonine kinases known as phosphatidylinositol 3-ki-
nase related kinases (PIKKs). IP6 stimulates DNA repair by
non-homologous end joining with mammalian proteins in vitro
(22). Non-homologous end joining can be reconstituted in vitro
with a limited number of purified proteins, including the Ku
heterodimer, which binds DNA ends and IP6 (23, 24), and the
PIKK, DNA-dependent protein kinase (DNA-PKcs) (reviewed in
Refs. 25 and 26). Other PIKKs, namely ataxia telangiectasia
mutated (ATM) and ataxia telangiectasia and Rad3-related
(ATR) gene products in mammalian cells and Tel1 and Mec1 in
yeast, have been shown to have important activities in DNA
damage checkpoint and telomere maintenance (27–29).
Telomeres are specialized protein-nucleic acid structures at
the ends of linear, eukaryotic chromosomes that preserve ge-
netic information during DNA replication, promote genomic
stability, and are important in both cellular senescence and
oncogenic transformation (reviewed in Refs. 30–32). Telomeric
DNA is maintained through the action of the ribonucleoprotein
telomerase, which acts in late S-phase to add template-inde-
pendent, species-specific TG-rich repeats to the lagging strand,
ensuring that chromosome length and coding sequences are
maintained. Telomere length is heterogeneous among chromo-
somes and cells, with the average length established by a
dynamic equilibrium between forces that shorten (exonuclease
access, low telomerase activity) and those that lengthen telo-
meric sequences (capping proteins, high telomerase activity).
Here we describe a role for the phospholipase C-dependent IP
signaling pathway in the regulation of telomere length through
production of an inositol diphosphate, PP-IP4, synthesized by
Kcs1. This modulation is dependent on Tel1 providing a func-
tional connection between PIKKs and inositol phosphates
in vivo.
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EXPERIMENTAL PROCEDURES
Strains, Media, and Genetic Methods—Yeast strains used in this
study are isogenic with W303 (leu2–3,112 his3–11,15 ura3–1 ade2–1
trp1–1 rad5–535 can1–100) except for changes introduced by transfor-
mation as indicated. Yeast were grown either in standard rich (yeast-
peptone-dextrose) medium or in complete minimal medium containing
2% glucose or galactose and lacking appropriate nutrients to verify and
maintain plasmids and markers. Yeast genetic manipulations were
performed using standard procedures. Deletion strains plc1::KANMX,
ipk2::KANMX, ipk1::KANMX, tel1::ura3, and yku70::ura3 ura3::HIS3
were generated as described previously (7, 12, 33, 34). Double and triple
deletion strains were constructed by mating to isogenic strains of the
opposite mating type followed by sporulation of the resulting diploid
and dissection of tetrads. Nutrient requirements, inositol labeling, and
PCR were used to screen spores for double mutations.
The entire KCS1 and DDP1 open reading frames were deleted from
the diploid Saccharomyces cerevisiae strain W303 and replaced with the
selectable marker HIS3 as described (35). Tetrads were dissected using
a Zeiss micromanipulator following sporulation of the heterozygous
diploids on 0.3% potassium acetate plates. The kcs1::HIS3 and
ddp1::HIS3 spores both segregated 2:2 (not shown) and were identified
by growth patterns on medium lacking histidine as well as by PCR
analysis.
Gene Identification and Plasmid Construction—To identify candidate
mammalian inositol diphosphoryl synthases, human expressed sequence
tag data bases were searched with BLASTP, gapped BLASTP, or
TBLASTN with appropriate query sequences. The full-length human
cDNA 646420 (designated as hIP6K, an orthologue of yeast Kcs1) was
obtained from Research Genetics, Inc. as an insert in pBluescript SK().
The entire open reading frame minus the codons for the first six amino-
terminal amino acids was inserted in-frame into the NcoI and XhoI sites
of pGEX-KG, derived from pGEX-2T (Amersham Biosciences) and kindly
donated by Dr. John Moskow in the laboratory of Dr. Daniel Lew (Duke
University, Department of Pharmacology and Cancer Biology), to gener-
ate pGEX-hIP6K. The entire open reading frame of the KCS1 gene was
amplified by polymerase chain reaction (PCR) from S. cerevisiae genomic
DNA and inserted into a pGEX vector to create an amino-terminal glu-
tathione S-transferase fusion. Primers were designed to incorporate
EcoRI sites in-frame with the initiation sites and to place XhoI sites after
the stop codons. Catalytically inactive Kcs1 was generated by a PCR
strategy converting both Asp791 and Lys793 to alanine. The presence of the
desired mutations was confirmed by sequencing the resulting construct
termed pGEX-kcs1kin. Complementation analyses in haploid kcs1
strains were performed by expressing wild type and catalytically inactive
forms of Ksc1 and hIP6K using the episomal plasmid pRS426 containing
a galactose-inducible promoter. In each case, the insert was removed from
the pGEX vector with EcoRI and XhoI and ligated into the EcoRI-XhoI
sites of pRS426GAL. These constructs were termed pRS-KCS1, pRS-
kcs1kin, and pRS-hIP6K.
The construct for PLC1 overexpression was based on pYEX4T, mod-
ified by removal of the LEU2 sequence. The entire PLC1 coding se-
quence was removed in a BamHI-NotI fragment from the pGAL1–10-
PLC1 vector described previously and provided by Dr. Jeremy Thorner
(6). This fragment was inserted into the modified multiple cloning site
of the pYEX4T vector behind the CUP1 promoter with the resulting
plasmid pYEX-PLC1.
Inositol Radiolabeling of Yeast—Approximately 105 cells were inoc-
ulated into 1 ml of appropriately modified complete minimal medium
containing myo-[3H]inositol (American Radiolabel Corporation, St.
Louis, MO) and were labeled for 24 h with shaking at 30 °C. Soluble
inositols were harvested as described (35). Water-soluble inositol iso-
mers were frozen quickly in a dry ice-isopropanol bath and stored at
80 °C prior to HPLC analysis. To analyze inositol isomers, samples
were thawed, equilibrated to 10 mM ammonium phosphate, pH 3.5, and
resolved on a 4.6  125-mm Partisphere SAX-HPLC strong anion
exchange column (Whatman). Samples were eluted with the following
gradient: 10 mM ammonium phosphate increased linearly to 1.7 M
ammonium phosphate over 25 min followed by an isocratic flow at 1.7
M ammonium phosphate for 50 min. Radioactivity was measured using
a BetaRAMTM in-line detector (INUS Systems, Tampa, FL). Individual
IP isomers were assigned in the chromatograms as described (12).
PP-IP4 and PP-IP5 were assigned based on published elution profiles
and sensitivity to hydrolysis by mammalian diphosphoryl inositol py-
rophosphatase (36).
Southern Analysis of Telomere Length—Details of this analysis are
as published previously (37). Genomic DNA was prepared from 5-ml
cultures grown to saturation and digested with PstI before electro-
phoresis on a 1% Tris borate-EDTA-agarose gel. The fragments were
transferred to Hybond N nylon membranes (Amersham Biosciences)
and hybridized at 65 °C to a probe derived from pYT14 containing
telomeric DNA and a portion of the Y subtelomeric repeat. The probe
was labeled with [-32P]dCTP using Ready-To-Go labeling beads (Am-
ersham Biosciences). Note that the Southern blot strategies are the
accepted methods in the field; however, the effect appears small be-
cause the PstI site used for cleaving is about 800 bp from the chromo-
some end. Thus less than half of the fragment is composed of telomeric
sequences. The bottom smear represents the terminal fragment result-
ing from cutting at the last Y elements (one of the subtelomeric re-
peats) on the chromosome. The bands near the top of the gel reflect
hybridization to fragments generated by cutting tandem Y elements of
two different sizes. These bands vary in intensity, even in wild-type
strains, probably as a consequence of a high rate of unequal recombi-
nation. Although we cannot exclude the possibility that there is a
somewhat higher rate of this type of recombination in one or more of the
mutants, none of them has the dramatic phenotype seen in yeast
strains undergoing alternative lengthening of telomere recombination,
where the upper bands become extremely prominent. For example, see
Fig. 3 in Ritchie et al. (37).
RESULTS
Genetics of Inositol Polyphosphate Synthesis in S. cerevi-
siae—A graphic summary of the metabolism of soluble inositol
phosphates in budding yeast is depicted in Fig. 1. A single
phospholipase C (Plc1) and three inositol polyphosphate ki-
nases, Ipk2, Ipk1, and Kcs1, function to generate over seven
species of water-soluble IP messengers. Plc1 hydrolyzes phos-
phatidylinositol 4,5-bisphosphate (PIP2) to release IP3 from the
membrane (6). IP3 serves as substrate for the nuclear inositol
kinase Ipk2 (also known as Arg82), which phosphorylates both
the D-6 and D-3 position hydroxyl groups to produce IP5 (7, 38).
IP5 is phosphorylated at the 2-hydroxyl by Ipk1 to generate IP6
(12). Kcs1 has been reported to function as a inositol diphos-
phoryl synthase to produce PP-IP4 and PP-IP5 from IP5 and IP6
substrates, respectively (17). Dephosphorylation of inositol
diphosphates occurs through a phosphatase Ddp1 (36).
To further study the role of these kinases and phosphatases
in inositol metabolism we analyzed a series of yeast mutant
strains using isotopic equilibrium radiolabeling. Steady state
metabolic radiolabeling of wild-type yeast cells with [3H]inosi-
tol indicates that the major soluble IP is IP6, representing 2%
of the recovered radioactivity from soluble cellular extracts
(Fig. 2). Other IPs, including PP-IP5, are present at low levels
FIG. 1. Schema of phospholipase C-dependent inositol
polyphosphate metabolism in S. cerevisiae. A single phospholipase
C (Plc1) hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to re-
lease IP3 from the membrane. IP3 serves as substrate for the inositol
kinase Ipk2, which phosphorylates both the D-6 and D-3 position hy-
droxyl groups to produce Ins(1,3,4,5,6)P5. IP5 is then phosphorylated by
Ipk1 at the 2-hydroxyl to generate IP6. IP6 can be further phosphoryl-
ated to PP-IP5 by one of two inositol diphosphoryl synthases in this
strain, Kcs1, or a second kinase, Ids1. Kcs1 also phosphorylates IP5 to
make PP-IP4. The kinase(s) responsible for synthesis of PP2-IP3 is
currently not defined, although it is likely that Kcs1 or Ids1 functions at
this step. The inositol diphosphates PP-IP4, PP2-IP3, and PP-IP5 are
dephosphorylated to IP5 and IP6 by an inositol diphosphoryl phospha-
tase Ddp1. Note that the ring position phosphates that Kcs1 and Ids1
phosphorylate are undetermined; thus it is possible that the PP-IP5
products of each kinase are distinct isomers (which are omitted from the
diagram only for the sake of simplicity).
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but are not observed under these labeling conditions (therefore
HPLC traces only show relevant times of elution). A significant
branch point in the IP pathway is exposed in metabolically
labeled cells upon deletion of the IP5 2-kinase (ipk1) cells,
which accumulate IP5 and a diphosphoryl inositol, PP-IP4 (Fig.
2A) (12). Deletion of KCS1 in the ipk1 strain abrogates the
peak of PP-IP4, which can be complemented with active Kcs1;
thus production of PP-IP4 is primarily dependent on Kcs1 in
vivo (Fig. 2A) (17). Disruption of KCS1 alone does not alter IP6
levels, demonstrating that PP-IP4 is not required for synthesis
of IP6 (Fig. 2A). Disruption of the DDP1 gene exposes a peak of
PP-IP5, which is not seen at appreciable levels in wild-type cells
(Fig. 2B) (36). Elimination of KCS1 in the ddp1 strain (kcs1
ddp1) leads to an increase rather than an ablation of PP-IP5
production (Fig. 2B), demonstrating the existence of a second
inositol diphosphoryl synthase (designated Ids1), which phos-
phorylates IP6 to a PP-IP5 isomer (see Fig. 1 schematic). This is
surprising in light of the published work of others that Kcs1 is
the major IP6 kinase activity in yeast (17). Cellular extracts
prepared from kcs1 ddp1 mutants have significant IP6 ki-
nase activity, further indicating the presence of a second kinase
(data not shown). Additionally, it does not appear that Ids1 is
encoded by IPK2, as extracts from ipk2 kcs1 mutant cells
harbor IP6 kinase activity, and we were not able to detect this
activity using recombinant Ipk2 under a range of conditions
(data not shown).
It is noteworthy that the chemical nature of the PP-IP5
isomers generated by Kcs1 and Ids1 are not known; thus it is
plausible that these kinases phosphorylate different positions,
thereby generating distinct PP-IP5 products that are not re-
solved by our HPLC analysis. The observed elevation of PP-IP5
in the kcs1 ddp1 strain suggests either that: 1) Ids1 activity
is negatively regulated by Kcs1 and/or one of its products; or 2)
Kcs1 converts the product of Ids1 to PP2-IP4; thus when Kcs1 is
deleted, PP-IP5 accumulates. Ids1 activity may also function as
a minor kinase relative to Kcs1 in the synthesis of PP-IP4 from
Ins(1,3,4,5,6)P5 as analysis of ipk1 kcs1ddp1 mutant cells
reveals a small but significant peak of PP-IP4 (not shown).
Furthermore, PP2-IP3 derivatives are observed when DDP1 is
eliminated in ipk1 strains; however, it is not known whether
Kcs1 or Ids1 activity is responsible for generating this prod-
uct(s). Collectively, our new results along with previously pub-
lished data lead to the schematic pathway depicted in Fig. 1.
Inositol Phosphates and Telomere Length in Vivo—Evidence
implicating IPs in the regulation of nuclear function and DNA
repair processes in mammalian and yeast systems provided the
impetus to examine these pathways in budding yeast. Exami-
nation of non-homologous end joining repair in plc1, ipk2, ipk1,
or kcs1 mutant yeast revealed that loss of inositol signaling
pathways does not result in detectable disruption of non-ho-
mologous end joining in living yeast (data not shown). It is of
interest that yeast possess two PIKKs, Tel1 and Mec1, which
are orthologues of ATM and ATR that play an important evo-
lutionarily conserved role in the regulation of telomere length.
We therefore continued our examination of PIKK-related func-
tion by determining the length of telomeres in yeast defective
in inositol metabolism. We find that strains with the genotypes
plc1, ipk2, or kcs1 have similarly elongated telomeres,
averaging 375 bp as compared with the average of 325 bp
observed in wild-type cells (Fig. 3A). In contrast, ipk1 cells
have telomeres slightly shorter than wild type (Fig. 3A). The
change in IP profile shared among the first three mutant
strains is the inability to synthesize the diphosphoryl inositols
PP-IP4 (and downstream higher phosphorylated forms such as
PP2-IP3) and PP-IP5 (Fig. 1). The ipk1 cells have a telomere
shift in the opposite direction, fail to synthesize IP6 and PP-IP5,
and have increased PP-IP4 levels (Fig. 2). This finding clearly
demonstrates that loss of PP-IP5 production is not responsible
for the lengthened telomeres. Instead, these data implicate
PP-IP4 production or a downstream metabolite as a negative
regulator of telomere length. Importantly, kcs1 cells do not
universally display the defects in gene expression or mRNA
export observed in plc1, ipk2, or ipk1 cells, suggesting that
the observed telomere phenotype is distinct from the previously
reported nuclear activities of IP4, IP5, and/or IP6. Furthermore,
the kcs1 ddp1 strain, which accumulates large amounts of
PP-IP5, has long telomeres identical to kcs1 alone (not
shown). Wild-type telomere length is observed in ddp1
strains, and double and triple mutants for ddp1, ipk1, and
kcs1 are consistent with loss of Kcs1 being a dominant phe-
FIG. 2. Steady state analysis of
inositol polyphosphates in mutant
strains. Haploid yeast strains were la-
beled with [3H]inositol to steady state in
overnight cultures, and then soluble in-
ositols were isolated and analyzed by
HPLC. IP standards are indicated as ar-
rows. Strains in A are, top to bottom, wild
type (wt), kcs1, ipk1, ipk1 kcs1,
ipk1 kcs1 transformed with pRS-KCS1
(pKCS1), and ipk1 kcs1 transformed
with pRS-kcs1kin (pkcs1kin). Strains
in B are, top to bottom, wild type, ddp1,
and ddp1 kcs1.
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notype. Collectively, these results implicate phospholipase C-
dependent PP-IP4 production through Kcs1 activity as a nega-
tive regulator of telomere length.
To test whether increases in PP-IP4 production would lead to
further telomere shortening, we overexpressed PLC1 in several
mutant strains, which (based on our previous studies) signifi-
cantly elevates IP production in cells (12). Wild-type strains
overexpressing PLC1 have increased IP6 levels (20-fold), no
detectable increase in PP-IP4 levels, and normal telomere
length (Fig. 3B). In contrast, ipk1 cells overexpressing PLC1
have significantly elevated levels of PP-IP4 (not shown) and
undergo further shortening of telomeres to an average length of
265 bp from the 325 bp observed in wild type (Fig. 3B). When
Kcs1 is eliminated from this strain, the cells again have a long
telomere phenotype (Fig. 3B). These data are consistent with a
gain of function effect mediated by PP-IP4. Comparing the
telomere lengthening in the absence of inositol diphosphates
and the shortening seen with increases in Plc1- and Kcs1-
mediated production of PP-IP4, we see a range of modulation of
telomere length of over 120 bp, accounting for roughly one-
third of the total wild-type telomere length (Fig. 3B).
To confirm that inositol kinase activity is required for normal
telomere length, we examined telomeres in kcs1 strains com-
plemented with either wild-type Kcs1, kinase-inactivated Kcs1
(kcs1kin), or a human inositol diphosphoryl synthase (hIP6K)
(Fig. 4). Both Kcs1 and hIP6K expression complement telomere
length in the kcs1 strain, whereas Kcs1 kinase-inactive ex-
pression does not (Fig. 4), demonstrating that kinase activity is
required. The ability of Kcs1 to complement in dextrose indi-
cated that the GAL promoter was not “off” and may be leaky in
these strains. We therefore performed complementation anal-
ysis in the ipk1 kcs1 strains, which enable detection and
quantification of PP-IP4. Indeed, the Kcs1 strains produced
significant levels of PP-IP4 even in dextrose, confirming the
leaky expression. Furthermore, growth of cells in galactose,
which is a strong inducer of GAL promoters, only modestly
elevated PP-IP4 levels as compared with dextrose (Fig. 4).
Analysis of ipk1 kcs1 complemented strains confirm that
expression of KCS1 restores telomere length equivalent to the
ipk1 strain alone (Fig. 4). Intriguingly, expression of inactive
kinase in this strain not only fails to complement telomere
length but also further lengthens telomeres, suggestive of a
direct kinase-effector protein interaction at the telomere (Fig.
4). Consistent with this idea, hIP6K only partially restores
telomere length to the length observed in ipk1 cells in the
ipk1 kcs1 mutant cells, despite PP-IP4 synthesis equivalent
to exogenous Kcs1 (HPLC data not shown). These results indi-
cate a requirement for kinase activity and PP-IP4 production,
as well as a possible role for a non-catalytic protein component,
such as a determinant that mediates proper localization or
regulation.
Kcs1 Regulation of Telomeres Requires Tel1—With this evi-
dence for PP-IP4 as a regulator of telomere length, we used
genetics to identify other components of the novel PP-IP4 path-
way. Because of the initial report that IP6 interacts with DNA-
dependent protein kinase, we considered Tel1 and Ku70/80 to
be reasonable effector candidates, because both have important
yet independent roles in maintenance of the yeast telomere
(34). We predicted that the effect of PP-IP4 would be absent in
cells missing a critical component of the IP effector pathway.
Analysis of yku70 mutant cells indicates an average telomere
length of 150 bp (Fig. 5A), consistent with published reports.
Double (ipk1 yku70 and kcs1 yku70) and triple (ipk1
kcs1 yku70) mutant strains were constructed and tested for
telomere length (Fig. 5A). In a yku70 background, the loss of
Kcs1 function again lengthens telomeres about 50 bp (average
length of 200 bp) consistent with Ku and Kcs1 functioning in
independent pathways. To probe the gain of the PP-IP4 effect
on shortening telomeres in the absence of Ku, we examined
telomere length in both yku70 ipk1 (Fig. 5A) and yku70
ipk1 overexpressing Plc1 (not shown). Neither condition re-
sulted in further shortening beyond the 150-bp length. Fur-
thermore, we did not find evidence of recombination or senes-
cence to suggest telomeres have reached a critical length,
indicating either the gain of function effect cannot be repro-
duced in the setting of short telomeres or is dependent on the
Ku pathway.
In contrast, all effects of PP-IP4 at the telomere are abolished
in the absence of Tel1. Both the double (ipk1 tel1 and kcs1
tel1) and triple (ipk1 kcs1 tel1) mutant strains have sta-
ble, shortened telomeres indistinguishable from tel1 cells
(Fig. 5B). This result indicates that the IPs function in the
same pathway of telomere regulation as this ATM homologue.
Because loss of Tel1 function leads to short telomeres, the data
are consistent with Kcs1 production of PP-IP4 acting as a
negative regulator of Tel1 function.
DISCUSSION
Here we report a novel role of a phospholipase C-dependent
signaling pathway in the control of telomere length. Individual
deletion of each of the three enzymes in the synthetic pathway
to PP-IP4 causes an identical lengthening of telomeres. The
long telomere phenotype is seen in yeast lacking all soluble
inositol phosphates (plc1-null) as well as in those lacking only
FIG. 3. Telomere analysis of inositol-signaling mutants. A, loss
of function mutants. The strains indicated were grown in yeast-pep-
tone-dextrose medium, and genomic DNA was prepared and probed for
telomeric sequences. Strain is indicated below each lane. From left,
these are wild type (wt), plc1, ipk2, kcs1, and ipk1. Molecular
weight standards are indicated by the arrows to the left. B, gain of
function mutants. Wild type, ipk1, and ipk1 kcs1 strains were
transformed with pYEX vector control () or pYEX-PLC1 (), grown in
complete minimal medium-Ura, and probed for telomere length as in A.
Strains are indicated below each lane. From left, these are wild type 
pYEX, wild type  pYEX-PLC1, ipk1  pYEX, ipk1  pYEX, and
ipk1 kcs1  pYEX. Vec, vector.
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Kcs1 kinase activity, which do synthesize PP-IP5 by way of Ids1
activity. Because ipk1-null cells with no PP-IP5 have the oppo-
site phenotype, loss of PP-IP5 cannot explain the longer te-
lomeres observed. Therefore the kinase activity of Kcs1 must be
producing something else, proximal to IP6 on the IP pathway,
which is needed for normal telomere length. Because IP5 is a
known substrate for Kcs1, the simplest interpretation is that
PP-IP4 loss leads to longer telomeres. We cannot formally ex-
clude PP2-IP3 and other molecules downstream of PP-IP4 or
Kcs1 phosphorylation of another inositol substrate such as IP4
as the molecules acting at the telomere. Importantly, we also
report that further increases in PP-IP4 synthesis lead to fur-
ther shortening of telomeres. The opposing effects of gain and
loss of PP-IP4 demonstrate that this signaling molecule regu-
lates the equilibrium of telomere length. These dual criteria
also distinguish Kcs1 and its products from a number of re-
ported genes involved in the maintenance of telomeres in yeast,
most of which have only been reported to either lengthen or
shorten telomeres but not both. Such regulation by a signaling-
activated intracellular messenger pathway puts telomere
maintenance under the potential control of extracellular stim-
uli, providing a mechanism to alter the average telomere
length based on growth conditions or other environmental
inputs.
Because neither the loss nor gain of PP-IP4 has any impact
on telomere length in the absence of Tel1, our work also pro-
vides a novel functional interaction between IPs and the activ-
ity of a PIKK family member, linking two important nuclear
signaling pathways. Given that loss of Tel1 and increase in
PP-IP4 both lead to shortened telomeres, the simplest explana-
tion is that PP-IP4 inhibits Tel1 kinase function, either through
direct or indirect kinase inhibition, consistent with Tel1 being
a downstream component of this IP pathway. Assigning Kcs1 a
FIG. 5. Regulation of telomere length by Kcs1 is independent
of Ku but dependent on Tel1. A, epistasis analysis of KCS1, IPK1,
and YKU70 at the telomere. B, epistasis analysis of KCS1, IPK1, and
TEL1 at the telomere. For both panels, single, double, and triple mutant
strains were generated from spores grown for at least 100 doublings
prior to the Southern analysis shown. Genotypes are indicated below
each lane. The length of wild-type (wt) telomeres is indicated by the oval
and arrow on right.
FIG. 4. Complementation of telo-
mere phenotype requires Kcs1 ki-
nase activity. ipk1 or ipk1 kcs1 cells
were transformed with plasmids encoding
various inositol diphosphoryl synthases
behind a GAL10 promoter. Cultures were
grown in complete minimal medium-Ura
with either dextrose (D) or galactose (G)
as carbon source, and telomeric sequences
were probed as described under “Experi-
mental Procedures.” The plasmids, from
left to right, are pKCS1 (encoding wild-
type Kcs1), pVEC (empty vector control),
pkcs1kin (encoding an active site point
mutant of Kcs1), and pIP6K (encoding a
human inositol diphosphoryl synthase).
The length of wild type (wt) telomeres is
indicated by the oval and arrow on right.
nd, not detected.
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role as a negative regulator of Tel1 activity is consistent with
earlier reports of the initial cloning of KCS1 as a second site
suppressor of a mitotic recombination phenotype (20) because
loss of Tel1 function increases recombination rates (33). Tel1 is
not the only potential target of IP regulation as other candidate
effectors in this pathway of telomere regulation include the
Mre11Rad50Xrs2 protein complex components, but their pre-
cise biochemical roles at the telomere remain elusive. Because
the Mre11Rad50Xrs2 complex as well as Tel1 favors length-
ening telomeres, they must somehow favor telomerase access to
the telomere end, and it is likely that the activity of Kcs1
opposes that access, thus changing the equilibrium to favor
average loss of telomere sequence. Given the reported roles for
Kcs1 and inositol diphosphates in cellular signaling events, we
cannot rule out at this point that other processes are involved.
Other important regulators may be gleaned from recent studies
describing a genome-wide screen for deletion mutants with a
telomere phenotype that yielded many mutants with length
alterations similar to the plc1 and kcs1 phenotypes (39). The
components of the PP-IP4 pathway were not identified in this
laborious screen; however, the authors concede they failed to
identify one-third of the described previously deletion strains
with telomere phenotypes. The existence of mammalian homo-
logues for both the inositol diphosphoryl synthases and Tel1
indicates that such an interaction may have important impli-
cations for human disease.
Our data expand the role of IPs in nuclear function and
provide new insights into the complexity of the described met-
abolic pathways of soluble IPs in yeast. Activation of phospho-
lipase C produces several unique IP messengers, which have
been found to modulate nuclear processes including transcrip-
tional control, chromatin remodeling, and mRNA export. We
see that the loss of Ipk1 activity uncovers a branch point in the
IP synthetic pathway that, despite its low abundance at steady
state, plays a significant regulatory role in the cell. Our evi-
dence for a regulatory role of the diphosphoryl inositol PP-IP4
in determining the telomere length set point reinforces the
hypothesis that a primordial role of phospholipase C activation
is to generate an ensemble of IP messengers to control several
nuclear events.
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